Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Sabin Inactivated Poliovirus Vaccine in Infants
NCT03822754Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jun 2018
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started Jun 2018; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03822754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822754.